Lonza launches new cell culture medium

• Customers realize higher product yields, improved cellular metabolism, a more reliable process and a lower total cost of goods.
• Medium and feed platform is free from royalty and license fees.
• Includes GS CHO-specific chemically defined, animal component-free (CDACF) cell culture medium, feed base powders and supplements

BASEL, SWITZERLAND: Lonza is launching a new cell culture medium and feed platform for the GS Gene Expression System that achieves product yields up to 10g/L. The CDACF “Version 8” platform, together with the GS System, forms the backbone of Lonza’s robust and reliable mammalian production technology.

“Lonza understands the need to innovate and help our growing GS customer base realize immediate cost savings during early-phase development. We are very confident that this latest improvement will be a significant advancement for mammalian bio production,” said Janet White, Head, Development Services, Lonza. 

Developed with Lonza’s extensive experience in biological manufacturing, the CDACF Version 8 platform realizes higher product yields and improved cellular metabolism to achieve a more robust process.

(C) WOC News